|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Current assets | |||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||
| Marketable securities | |||||||||||||||||
| Trade and other receivables, net | |||||||||||||||||
| Loans and merchant cash advances, net | |||||||||||||||||
| Other current assets | |||||||||||||||||
| Total current assets | |||||||||||||||||
| Long-term assets | |||||||||||||||||
| Property and equipment, net | |||||||||||||||||
| Operating lease right-of-use assets, net | |||||||||||||||||
| Intangible assets, net | |||||||||||||||||
| Deferred tax assets | |||||||||||||||||
| Other long-term assets | |||||||||||||||||
| Long-term investments | |||||||||||||||||
| Equity and other investments ($3,205 and $3,619, carried at fair value) | |||||||||||||||||
| Equity method investment | |||||||||||||||||
| Goodwill | |||||||||||||||||
| Total long term assets | |||||||||||||||||
| Total assets | |||||||||||||||||
| Liabilities and shareholders’ equity | |||||||||||||||||
| Current liabilities | |||||||||||||||||
| Accounts payable and accrued liabilities | |||||||||||||||||
| Income taxes payable | |||||||||||||||||
| Deferred revenue | |||||||||||||||||
| Operating lease liabilities | |||||||||||||||||
| Convertible senior notes | |||||||||||||||||
| Total current liabilities | |||||||||||||||||
| Long-term liabilities | |||||||||||||||||
| Deferred revenue | |||||||||||||||||
| Deferred tax liability | |||||||||||||||||
| Operating lease liabilities | |||||||||||||||||
| Convertible senior notes | |||||||||||||||||
| Deferred tax liabilities | |||||||||||||||||
| Total long term liabilities | |||||||||||||||||
| Shareholders’ equity | |||||||||||||||||
| Common stock, unlimited Class A subordinate voting shares authorized, 1,208,317,826 and 1,225,830,706, issued and outstanding; unlimited Class B restricted voting shares authorized, 78,065,084 and 78,073,594 issued and outstanding; 1 Founder Share authorized, 1 and 1 issued and outstanding | |||||||||||||||||
| Additional paid-in capital | |||||||||||||||||
| Accumulated other comprehensive (loss) income | |||||||||||||||||
| Accumulated surplus | |||||||||||||||||
| Total shareholders’ equity | |||||||||||||||||
| Total liabilities and shareholders’ equity | |||||||||||||||||
Loading...